Renaissance Technologies
VTAK icon

Renaissance Technologies’s Catheter Precision VTAK Stock Holding History

Renaissance Technologies’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,260
Closed -$5.79K – 3982
2025
Q2 		$5.79K Buy
+1,260
New +$6.82K ﹤0.01% 3515
2024
Q3 		– Sell
-195
Closed -$21.6K – 3931
2024
Q2 		$21.6K Buy
+195
New +$19.8K ﹤0.01% 3377
2024
Q1 		– Sell
-129
Closed -$10K – 4115
2023
Q4 		$10K Buy
129
+8
+7% +$653 ﹤0.01% 3643
2023
Q3 		$10K Sell
121
-69
-36% -$8.02K ﹤0.01% 3584
2023
Q2 		$33K Sell
190
-22
-10% -$5.07K ﹤0.01% 3687
2023
Q1 		$62K Buy
+212
New +$115K ﹤0.01% 3611
2022
Q1 		– Sell
-15
Closed -$229K – 4512
2021
Q4 		$229K Buy
+15
New +$358K ﹤0.01% 3461
2021
Q2 		– Sell
-16
Closed -$725K – 3806
2021
Q1 		$725K Buy
16
+1
+7% +$65.4K ﹤0.01% 2753
2020
Q4 		$1.05M Buy
15
+1
+7% +$59.5K ﹤0.01% 2473
2020
Q3 		$990K Buy
14
+10
+250% +$796K ﹤0.01% 2532
2020
Q2 		$427K Buy
+4
New +$770K ﹤0.01% 2926

Other funds holding VTAK

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Renaissance Technologies's VTAK Position: Q3 2025 in Review

Renaissance Technologies sold out of Catheter Precision (VTAK) in Q3 2025, closing a stake of 1,260 shares — an estimated $5.79K sold.

Renaissance Technologies first reported a position in VTAK in Q2 2020 and held it in 11 quarters. The position peaked at $1.05M in Q4 2020. 3 funds tracked by Wall St. Rank hold VTAK as of Q3 2025.

  • Renaissance Technologies reported no remaining Catheter Precision position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 1,260 Catheter Precision shares in Q3 2025, an estimated $5.79K.
  • Renaissance Technologies first reported a position in Catheter Precision in Q2 2020 and held it in 11 quarters.
  • Renaissance Technologies's Catheter Precision position peaked at $1.05M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.